Ramachandran S. Vasan

193.1k total citations · 48 hit papers
955 papers, 108.8k citations indexed

About

Ramachandran S. Vasan is a scholar working on Cardiology and Cardiovascular Medicine, Physiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Ramachandran S. Vasan has authored 955 papers receiving a total of 108.8k indexed citations (citations by other indexed papers that have themselves been cited), including 564 papers in Cardiology and Cardiovascular Medicine, 140 papers in Physiology and 139 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Ramachandran S. Vasan's work include Cardiovascular Function and Risk Factors (203 papers), Blood Pressure and Hypertension Studies (156 papers) and Cardiovascular Health and Disease Prevention (136 papers). Ramachandran S. Vasan is often cited by papers focused on Cardiovascular Function and Risk Factors (203 papers), Blood Pressure and Hypertension Studies (156 papers) and Cardiovascular Health and Disease Prevention (136 papers). Ramachandran S. Vasan collaborates with scholars based in United States, Germany and Australia. Ramachandran S. Vasan's co-authors include Daniel Levy, Martin G. Larson, Emelia J. Benjamin, Ralph B. D’Agostino, Thomas J. Wang, Ralph B. D' Agostino, Joseph M. Massaro, Michael J. Pencina, William B. Kannel and Philip A. Wolf and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Ramachandran S. Vasan

927 papers receiving 105.8k citations

Hit Papers

General Cardiovascular Risk Profile for Use in Pri... 1995 2026 2005 2015 2008 2007 2011 2007 2002 1000 2.0k 3.0k 4.0k 5.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. General Cardiovascular Risk Profile for Use in Primary Care
    2008 5.3k citations Ralph B. D’Agostino, Ramachandran S. Vasan et al. Circulation profile →
  2. Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond
    2007 5.0k citations Ramachandran S. Vasan et al. profile →
  3. Metabolite profiles and the risk of developing diabetes
    2011 2.3k citations Thomas J. Wang, Martin G. Larson et al. profile →
  4. Abdominal Visceral and Subcutaneous Adipose Tissue Compartments
    2007 2.2k citations Caroline S. Fox, Joseph M. Massaro et al. Circulation profile →
  5. Obesity and the Risk of Heart Failure
    2002 2.2k citations Satish Kenchaiah, Daniel Levy et al. profile →
  6. Vitamin D Deficiency and Risk of Cardiovascular Disease
    2008 1.9k citations Thomas J. Wang, Paul F. Jacques et al. Circulation profile →
  7. Arterial Stiffness and Cardiovascular Events
    2010 1.7k citations Gary F. Mitchell, Ramachandran S. Vasan et al. Circulation profile →
  8. Long-Term Trends in the Incidence of and Survival with Heart Failure
    2002 1.6k citations Daniel Levy, Satish Kenchaiah et al. profile →
  9. Impact of High-Normal Blood Pressure on the Risk of Cardiovascular Disease
    2001 1.5k citations Ramachandran S. Vasan, Martin G. Larson et al. profile →
  10. Lifetime Risk for Development of Atrial Fibrillation
    2004 1.5k citations Thomas J. Wang, Martin G. Larson et al. Circulation profile →
  11. Temporal Relations of Atrial Fibrillation and Congestive Heart Failure and Their Joint Influence on Mortality
    2003 1.5k citations Thomas J. Wang, Martin G. Larson et al. Circulation profile →
  12. Changes in Arterial Stiffness and Wave Reflection With Advancing Age in Healthy Men and Women
    2004 1.2k citations Gary F. Mitchell, Helen Parise et al. Hypertension profile →
  13. Plasma Natriuretic Peptide Levels and the Risk of Cardiovascular Events and Death
    2004 1.2k citations Thomas J. Wang, Martin G. Larson et al. profile →
  14. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study
    2015 1.1k citations Renate B. Schnabel, Xiaoyan Yin et al. profile →
  15. Lifetime Risk for Developing Congestive Heart Failure
    2002 1.1k citations Martin G. Larson, Alexa Beiser et al. Circulation profile →
  16. Obesity and Systemic Oxidative Stress
    2003 1.1k citations Martin G. Larson, Ramachandran S. Vasan et al. profile →
  17. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction
    1999 1.1k citations Ramachandran S. Vasan, Martin G. Larson et al. profile →
  18. Dose-response associations between accelerometry measured physical activity and sedentary time and all cause mortality: systematic review and harmonised meta-analysis
    2019 1.0k citations Martin G. Larson, Nicole L. Spartano et al. profile →
  19. The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective
    2013 979 citations Daniel Levy, Ramachandran S. Vasan et al. profile →
  20. Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and Death
    2006 976 citations Thomas J. Wang, Martin G. Larson et al. profile →
  21. Residual Lifetime Risk for Developing Hypertension in Middle-aged Women and Men
    2002 960 citations Ramachandran S. Vasan, Alexa Beiser et al. profile →
  22. Biomarkers of Cardiovascular Disease
    2006 853 citations Ramachandran S. Vasan Circulation profile →
  23. Pericardial Fat, Visceral Abdominal Fat, Cardiovascular Disease Risk Factors, and Vascular Calcification in a Community-Based Sample
    2008 831 citations Joseph M. Massaro, Ramachandran S. Vasan et al. Circulation profile →
  24. Body Mass Index, Metabolic Syndrome, and Risk of Type 2 Diabetes or Cardiovascular Disease
    2006 820 citations James B. Meigs, Peter W.F. Wilson et al. profile →
  25. Aortic Stiffness, Blood Pressure Progression, and Incident Hypertension
    2012 781 citations Jian Rong, Martin G. Larson et al. profile →
  26. Impact of Obesity on Plasma Natriuretic Peptide Levels
    2004 771 citations Thomas J. Wang, Martin G. Larson et al. Circulation profile →
  27. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study
    2001 757 citations Ramachandran S. Vasan, Martin G. Larson et al. profile →
  28. Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study
    2009 754 citations Renate B. Schnabel, Lisa Sullivan et al. profile →
  29. Visceral and Subcutaneous Adipose Tissue Volumes Are Cross-Sectionally Related to Markers of Inflammation and Oxidative Stress
    2007 739 citations Joseph M. Massaro, Ramachandran S. Vasan et al. Circulation profile →
  30. Soft Drink Consumption and Risk of Developing Cardiometabolic Risk Factors and the Metabolic Syndrome in Middle-Aged Adults in the Community
    2007 719 citations Ravi Dhingra, Lisa Sullivan et al. Circulation profile →
  31. Prevalence, clinical features and prognosis of diastolic heart failure: An epidemiologic perspective
    1995 691 citations Ramachandran S. Vasan, Emelia J. Benjamin et al. profile →
  32. Predicting the 30-Year Risk of Cardiovascular Disease
    2009 621 citations Michael Pencina, Ralph B. D’Agostino et al. Circulation profile →
  33. Inflammatory Markers and Risk of Heart Failure in Elderly Subjects Without Prior Myocardial Infarction
    2003 607 citations Ramachandran S. Vasan, Lisa Sullivan et al. Circulation profile →
  34. The Third Generation Cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: Design, Recruitment, and Initial Examination
    2007 593 citations Emelia J. Benjamin, Ralph B. D’Agostino et al. profile →
  35. A Risk Score for Predicting Stroke or Death in Individuals With New-Onset Atrial Fibrillation in the Community
    2003 586 citations Thomas J. Wang, Joseph M. Massaro et al. profile →
  36. Cross-Sectional Relations of Digital Vascular Function to Cardiovascular Risk Factors in the Framingham Heart Study
    2008 578 citations Naomi M. Hamburg, Michelle J. Keyes et al. Circulation profile →
  37. Low-Grade Albuminuria and Incidence of Cardiovascular Disease Events in Nonhypertensive and Nondiabetic Individuals
    2005 558 citations James B. Meigs, Thomas J. Wang et al. Circulation profile →
  38. Atrial Fibrillation Begets Heart Failure and Vice Versa
    2016 550 citations Martin G. Larson, Jared W. Magnani et al. Circulation profile →
  39. Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association
    2016 539 citations Gregg C. Fonarow, Ramachandran S. Vasan et al. Circulation profile →
  40. Defining Diastolic Heart Failure
    2000 521 citations Ramachandran S. Vasan, Daniel Levy Circulation profile →
  41. Epidemiology and Clinical Course of Heart Failure with Preserved Ejection Fraction
    2010 519 citations Ramachandran S. Vasan et al. profile →
  42. Relation of Disease Pathogenesis and Risk Factors to Heart Failure With Preserved or Reduced Ejection Fraction
    2009 512 citations Douglas S. Lee, Ramachandran S. Vasan et al. Circulation profile →
  43. Increasing Cardiovascular Disease Burden Due to Diabetes Mellitus
    2007 500 citations Caroline S. Fox, Ralph B. D’Agostino et al. Circulation profile →
  44. Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans
    2011 481 citations Susan Cheng, Martin G. Larson et al. profile →
  45. Epidemiology of cardiovascular disease in young individuals
    2017 461 citations Charlotte Andersson, Ramachandran S. Vasan profile →
  46. Prognostic Utility of Novel Biomarkers of Cardiovascular Stress
    2012 391 citations Thomas J. Wang, Martin G. Larson et al. Circulation profile →
  47. Temporal Trends in the Incidence of and Mortality Associated With Heart Failure With Preserved and Reduced Ejection Fraction
    2018 361 citations Connie W. Tsao, Asya Lyass et al. JACC Heart Failure profile →
  48. Association of Smoking Cessation With Subsequent Risk of Cardiovascular Disease
    2019 234 citations Ramachandran S. Vasan et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ramachandran S. Vasan United States 146 57.4k 16.8k 16.0k 15.2k 13.8k 955 108.8k
Martin G. Larson United States 142 53.4k 0.9× 10.6k 0.6× 9.6k 0.6× 9.0k 0.6× 12.7k 0.9× 587 89.4k
Daniel Levy United States 171 90.7k 1.6× 11.3k 0.7× 19.4k 1.2× 13.8k 0.9× 25.2k 1.8× 816 143.1k
Josef Coresh United States 133 30.8k 0.5× 9.1k 0.5× 16.9k 1.1× 14.4k 1.0× 16.1k 1.2× 952 116.0k
Albert Hofman Netherlands 166 27.4k 0.5× 17.4k 1.0× 9.1k 0.6× 13.4k 0.9× 11.6k 0.8× 1.5k 122.0k
Peter W.F. Wilson United States 156 35.2k 0.6× 13.3k 0.8× 29.9k 1.9× 14.4k 0.9× 31.0k 2.2× 646 110.5k
Emelia J. Benjamin United States 141 70.6k 1.2× 10.7k 0.6× 8.4k 0.5× 12.3k 0.8× 11.9k 0.9× 788 102.0k
Andrew S. Levey United States 130 30.9k 0.5× 8.2k 0.5× 13.6k 0.8× 15.4k 1.0× 17.8k 1.3× 514 125.4k
Salim Yusuf Canada 181 103.5k 1.8× 9.3k 0.6× 24.4k 1.5× 15.1k 1.0× 28.9k 2.1× 1.3k 157.0k
Russell P. Tracy United States 122 23.2k 0.4× 20.5k 1.2× 11.6k 0.7× 19.5k 1.3× 13.3k 1.0× 674 87.8k
Aaron R. Folsom United States 139 26.9k 0.5× 8.7k 0.5× 10.3k 0.6× 9.6k 0.6× 11.1k 0.8× 867 75.6k

Countries citing papers authored by Ramachandran S. Vasan

Since Specialization
Citations

This map shows the geographic impact of Ramachandran S. Vasan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ramachandran S. Vasan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ramachandran S. Vasan more than expected).

Fields of papers citing papers by Ramachandran S. Vasan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ramachandran S. Vasan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ramachandran S. Vasan. The network helps show where Ramachandran S. Vasan may publish in the future.

Co-authorship network of co-authors of Ramachandran S. Vasan

This figure shows the co-authorship network connecting the top 25 collaborators of Ramachandran S. Vasan. A scholar is included among the top collaborators of Ramachandran S. Vasan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ramachandran S. Vasan. Ramachandran S. Vasan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Greenberg, Jason H., Alison G. Abraham, Yunwen Xu, et al.. (2025). Biomarker Panels for Discriminating Risk of CKD Progression in Children. Journal of the American Society of Nephrology. 36(6). 1105–1115. 1 indexed citations
2.
Coca, Steven G., Heather Thiessen‐Philbrook, Joachim H. Ix, et al.. (2025). The distal nephron biomarkers associate with diabetic kidney disease progression. JCI Insight. 10(12). 1 indexed citations
3.
Domingo‐Relloso, Arce, Kathrin Schilling, Ronald A. Glabonjat, et al.. (2025). Uranium exposure and kidney tubule biomarkers in the Multi-Ethnic Study of Atherosclerosis (MESA). Environmental Research. 271. 121060–121060. 4 indexed citations
4.
Larson, Martin G., et al.. (2024). Modifiable risk factors and risk of myocardial infarction in offspring with parental disease. European Journal of Preventive Cardiology. 32(2). 131–138. 1 indexed citations
5.
Ekenze, Oluchi, Adlin Pinheiro, Serkalem Demissie, et al.. (2023). Inflammatory biomarkers and MRI visible perivascular spaces: The Framingham Heart Study. Neurobiology of Aging. 127. 12–22. 11 indexed citations
6.
Mitchell, Gary F., Jian Rong, Martin G. Larson, et al.. (2023). Vascular Age Assessed From an Uncalibrated, Noninvasive Pressure Waveform by Using a Deep Learning Approach: The AI-VascularAge Model. Hypertension. 81(1). 193–201. 7 indexed citations
7.
Mentias, Amgad, Neil Keshvani, Andrew Sumarsono, et al.. (2023). Patterns, Prognostic Implications, and Rural-Urban Disparities in Optimal GDMT Following HFrEF Diagnosis Among Medicare Beneficiaries. JACC Heart Failure. 12(6). 1044–1055. 10 indexed citations
8.
Wang, Dongyu, Martin G. Larson, Emily S. Lau, et al.. (2023). Family History of Modifiable Risk Factors and Association With Future Cardiovascular Disease. Journal of the American Heart Association. 12(6). e027881–e027881. 8 indexed citations
9.
Vasan, Ramachandran S., et al.. (2022). Multi-system trajectories and the incidence of heart failure in the Framingham Offspring Study. PLoS ONE. 17(5). e0268576–e0268576. 1 indexed citations
10.
Carneiro, Herman, Rebecca J. Song, Joowon Lee, et al.. (2021). Association of Blood Pressure and Heart Rate Responses to Submaximal Exercise With Incident Heart Failure: The Framingham Heart Study. Journal of the American Heart Association. 10(7). e019460–e019460. 9 indexed citations
11.
Lee, Joowon, Maura E. Walker, Nicole L. Spartano, et al.. (2021). Conjoint Associations of Adherence to Physical Activity and Dietary Guidelines With Cardiometabolic Health: The Framingham Heart Study. Journal of the American Heart Association. 10(7). e019800–e019800. 8 indexed citations
12.
Vasan, Ramachandran S., Vanessa Xanthakis, Asya Lyass, et al.. (2017). Epidemiology of Left Ventricular Systolic Dysfunction and Heart Failure in the Framingham Study. JACC. Cardiovascular imaging. 11(1). 1–11. 148 indexed citations
13.
Niiranen, Teemu, Bindu Kalesan, Naomi M. Hamburg, et al.. (2016). Relative Contributions of Arterial Stiffness and Hypertension to Cardiovascular Disease: The Framingham Heart Study. Journal of the American Heart Association. 5(11). 99 indexed citations
14.
Lubitz, Steven A., Xiaoyan Yin, Michiel Rienstra, et al.. (2015). Long-Term Outcomes of Secondary Atrial Fibrillation in the Community. Circulation. 131(19). 1648–1655. 151 indexed citations
15.
Rutter, Martin K., Lisa Sullivan, Caroline S. Fox, et al.. (2014). Baseline Levels, and Changes Over Time in Body Mass Index and Fasting Insulin, and Their Relationship to Change in Metabolic Trait Clustering. Metabolic Syndrome and Related Disorders. 12(7). 372–380. 10 indexed citations
16.
Pencina, Michael, Ralph B. D’Agostino, Martin G. Larson, Joseph M. Massaro, & Ramachandran S. Vasan. (2009). Predicting the 30-Year Risk of Cardiovascular Disease. Circulation. 119(24). 3078–3084. 621 indexed citations breakdown →
17.
Hamburg, Naomi M., Michelle J. Keyes, Martin G. Larson, et al.. (2008). Cross-Sectional Relations of Digital Vascular Function to Cardiovascular Risk Factors in the Framingham Heart Study. Circulation. 117(19). 2467–2474. 578 indexed citations breakdown →
18.
Lee, Douglas S., Joseph M. Massaro, Thomas J. Wang, et al.. (2007). Antecedent Blood Pressure, Body Mass Index, and the Risk of Incident Heart Failure in Later Life. Hypertension. 50(5). 869–876. 76 indexed citations
19.
Dhingra, Ravi, Lisa Sullivan, Paul F. Jacques, et al.. (2007). Soft Drink Consumption and Risk of Developing Cardiometabolic Risk Factors and the Metabolic Syndrome in Middle-Aged Adults in the Community. Circulation. 116(5). 480–488. 719 indexed citations breakdown →
20.
Mitchell, Gary F., Joseph A. Vita, Martin G. Larson, et al.. (2005). Cross-Sectional Relations of Peripheral Microvascular Function, Cardiovascular Disease Risk Factors, and Aortic Stiffness. Circulation. 112(24). 3722–3728. 236 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martin G. Larson Breakdown of academic impact, for papers by Daniel Levy Breakdown of academic impact, for papers by Josef Coresh Breakdown of academic impact, for papers by Albert Hofman Breakdown of academic impact, for papers by Peter W.F. Wilson Breakdown of academic impact, for papers by Emelia J. Benjamin Breakdown of academic impact, for papers by Andrew S. Levey Breakdown of academic impact, for papers by Salim Yusuf Breakdown of academic impact, for papers by Russell P. Tracy Breakdown of academic impact, for papers by Aaron R. Folsom
Rankless by CCL
2026